Closed · RFA-RM-10-007 · CFDA 93.310 · Discretionary
Production Of Human Proteins To Be Used For Generating Affinity Reagents (U01)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $600K
- Award range
- Closed
- Status
- April 26, 2010
- Close date
- 1
- Expected awards
The verdict
Production Of Human Proteins To Be Used For Generating Affinity Reagents (U01) is a closed discretionary listing from National Institutes of Health that offered Up to $600,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $600K
- award range
- Closed
- application status
- 1
- expected award
- 93.310
- CFDA program
Archived opportunity record
Production Of Human Proteins To Be Used For G… is closed (last close April 26, 2010). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed April 26, 2010
Est. Total Funding
$1,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
Purpose. This FOA is the first component of a pilot program organized under the NIH Common Fund Protein Capture Initiative to examine the feasibility and value of generating a community resource of high quality, renewable affinity reagents for all human proteins. This specific FOA topic is focused on the production of proteins or peptides for the purpose of generating monoclonal antibodies that can be used in immunoprecipitation studies, and potentially for other affinity reagents, as well as broader uses by the scientific community and others. Thus, the FOA solicits projects that will provide the targeted proteins, peptides or other immunogens to other components of the pilot program (including a component that will generate monoclonal antibodies, to be solicited in FY2011), as well as to the wider community in the form of a renewable resource, e.g., clones or transfected cell lines.This FOA will prioritize human transcription factors as an initial set of targets. Mechanism of Support. This FOA will utilize the U01 Research Project Cooperative Agreement activity code. Funds Available and Anticipated Number of Awards..We expect to fund a single three year award in FY2010. Total funds available for the program are $1M, for each of three years.. Budget and Project Period.Applications should propose no more than $600,000 in direct costs per year over a period of no more than three years.
Market-open applicant set · includes for-profit door
The eligibility set for Production Of Human Proteins To Be Used For G… includes a for-profit door among 10 printed types (State governments; Public / state-controlled institutions of higher education; Federally recognized tribal governments; Native American tribal organizations (other than Federally recognized tribal governments); +6 more). Competitive traffic can include commercial applicants alongside other listed classes. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). Only 91 other National Institutes of Health listings share this exact eligibility-code string (1% of 12,420).
- Code 00
- State governments
- Code 06
- Public / state-controlled institutions of higher education
- Code 07
- Federally recognized tribal governments
- Code 11
- Native American tribal organizations (other than Federally recognized tribal governments)
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 23
- Small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Production Of Human Proteins To Be Used For G… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.310 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |